Gene · 7409
Papers3,486
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,486
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of cytokine in malignant T-cell metabolism and subsequent alternation in T-cell tumor microenvironment. | Front Oncol | 2023 | 37746258 | PubTator, text mining | PubMed |
| The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG. | Nat Commun | 2023 | 37735473 | PubTator, text mining | PubMed |
| Extranodal lymphoma: pathogenesis, diagnosis and treatment. | Mol Biomed | 2023 | 37718386 | PubTator, text mining | PubMed |
| Background and roles: myosin in autoimmune diseases. | Front Cell Dev Biol | 2023 | 37691828 | PubTator, text mining | PubMed |
| FBXO21 mediated degradation of p85α regulates proliferation and survival of acute myeloid leukemia. | Leukemia | 2023 | 37689825 | PubTator, text mining | PubMed |
| UPR-Induced miR-616 Inhibits Human Breast Cancer Cell Growth and Migration by Targeting c-MYC. | Int J Mol Sci | 2023 | 37685841 | PubTator, text mining | PubMed |
| Multiplex interrogation of the NK cell signalome reveals global downregulation of CD16 signaling during lentivirus infection through an IL-18/ADAM17-dependent mechanism. | PLoS Pathog | 2023 | 37669308 | PubTator, text mining | PubMed |
| Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution. | Nat Genet | 2023 | 37666991 | PubTator, text mining | PubMed |
| Metabolic signature and proteasome activity controls synovial migration of CDC42hiCD14+ cells in rheumatoid arthritis. | Front Immunol | 2023 | 37662900 | PubTator, text mining | PubMed |
| Ectopic expression of DOCK8 regulates lysosome-mediated pancreatic tumor cell invasion. | Cell Rep | 2023 | 37651233 | PubTator, text mining | PubMed |
| HAPLN1 matrikine: a bone marrow homing factor linked to poor outcomes in patients with MM. | Blood Adv | 2023 | 37647592 | PubTator, text mining | PubMed |
| Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy. | Front Immunol | 2023 | 37638058 | PubTator, text mining | PubMed |
| Large-scale assessment of pros and cons of autopsy-derived or tumor-matched tissues as the norms for gene expression analysis in cancers. | Comput Struct Biotechnol J | 2023 | 37635765 | PubTator, text mining | PubMed |
| Peripheral T-Cell Lymphoma: From Biological Research to New Therapies. | Cancers (Basel) | 2023 | 37627220 | PubTator, text mining | PubMed |
| The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer. | Biology (Basel) | 2023 | 37626965 | PubTator, text mining | PubMed |
| A Systematic Compilation of Human SH3 Domains: A Versatile Superfamily in Cellular Signaling. | Cells | 2023 | 37626864 | PubTator, text mining | PubMed |
| TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through CD45 receptor. | Oncoimmunology | 2023 | 37593677 | PubTator, text mining | PubMed |
| Fluid shear stress enhances natural killer cell's cytotoxicity toward circulating tumor cells through NKG2D-mediated mechanosensing. | APL Bioeng | 2023 | 37575881 | PubTator, text mining | PubMed |
| A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma. | Blood Adv | 2023 | 37552109 | PubTator, text mining | PubMed |
| Vav1-dependent Rac1 activation mediates hypoxia-induced gemcitabine resistance in pancreatic ductal adenocarcinoma cells through upregulation of HIF-1α expression. | Cell Biol Int | 2023 | 37545183 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7409/papers?page=8